New treatment strategies for proliferative lupus nephritis: keep children in mind!

about

A treatment algorithm for children with lupus nephritis to prevent developing renal failure Therapies for multiple sclerosis: considerations in the pediatric patient.Treatment of young patients with lupus nephritis using calcineurin inhibitors.

P2860

Q27026880-57844EEF-5784-47DD-AA68-7425D165C808 Q37827690-0FEA4049-D4A3-4B08-B7CF-0113D32F0F4D Q38156915-CBEAF803-22B1-4279-BB3D-C62BA0BC74B7

P2860

New treatment strategies for proliferative lupus nephritis: keep children in mind!

Item

http://www.wikidata.org/entity/Q36915693

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

New treatment strategies for proliferative lupus nephritis: keep children in mind!

@en

type

Item

label

New treatment strategies for proliferative lupus nephritis: keep children in mind!

@en

prefLabel

New treatment strategies for proliferative lupus nephritis: keep children in mind!

@en

P1476

New treatment strategies for proliferative lupus nephritis: keep children in mind!

@en

P2093

B Ranchin

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Preven

Effective B cell depletion with rituximab in the treatment of autoimmune diseases.

Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort.

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study.

Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study.

Lupus nephritis in childhood: a review of 53 patients followed at a single center.

Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials.

Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies.

Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.

P304

684-691

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0961203307079810

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sonia Fargue

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17711908

http://www.w3.org/2001/XMLSchema#string

New treatment strategies for proliferative lupus nephritis: keep children in mind!

about

P2860

P2860

New treatment strategies for proliferative lupus nephritis: keep children in mind!

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698